[News] TAS-102 in metastatic colorectal cancer

A new study has found that trifluridine/tipiracil (TAS-102)significantly increases overall survival compared with that for placebo in Asian patients with advanced colorectal cancer, irrespective of whether they have been exposed to biological therapy.
Source: The Lancet Oncology - Category: Cancer & Oncology Authors: Tags: News Source Type: research